WHO vaccine-preventable diseases: monitoring system. 2015 global summary

Last updated 15-Jul-2015 (Data received as of 10-Jul-2015)
Next overall update Fall 2015
EPI mother and child logo         
Select a country

Development status: Developed economy GNI / capita (US$): 64'6801 Infant (under 12 months) mortality rate: 42
GDP / capita (US$): 43'9021 Child (under 5 years) mortality rate: 52

Population data in thousands3

  2014  2013  2012  2011  2010  2000  1990  1980 
Total population 23'630  23'343  23'050  22'741  22'404  19'259  17'097  14'708 
Births 311  308  305  302  299  249  255  228 
Surviving infants 309  307  304  301  297  248  253  226 
Pop. less than 5 years 1'585  1'565  1'539  1'505  1'458  1'290  1'262  1'135 
Pop. less than 15 years 4'517  4'452  4'389  4'321  4'244  3'995  3'767  3'715 
Female 15-49 years 5'643  5'617  5'590  5'559  5'522  4'922  4'518  3'670 

Number of reported case

(Click for retrospective incidence data for Australia)
Diphtheria
Japanese encephalitis
Measles 340  158  199  190  70  108  880 
Mumps 187  216  195  145  89  212 
Pertussis 11'842  12'319  23'855  38'040  34'285  5'795  862  124 
Polio*
Rubella 17  26  35  60  42  313 
Rubella (CRS)
Tetanus (neonatal)
Tetanus (total)**
Yellow fever
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV). For desagregated data please click on this hyperlink: https://extranet.who.int/polis/public/CaseCount.aspx
it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).
** Neonatal Tetanus and Total Tetanus cases equality may be the result from a lack of non-Neonatal Tetanus surveillance system.

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Australia)
Vaccine year result method % card seen                                                
BCG         
DTP1          92  92 
DTP3          92  91  92  92  92  90  95  33 
DTP4         
IPV1         
HepB_BD         
HepB3          91  91  92  92  92 
Hib3          91  91  92  92  92  90 
JapEnc         
MCV1          93  94  94  94  94  91  86 
MCV2          93  92  91  90  88 
PCV1          91 
PCV3          91  91  91 
Pol3          92  91  92  92  92  90  72  17 
Rota1          84 
Rota_last          84  84  84  85 
Rubella1          93  94  94  94  94 
TT2plus         
PAB         
VAD1         
YFV         
  ° indicates that more than 1 survey occurred that year

  Next update: Mid July 2016

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Australia)
DTP1 92  92  92  92  97  96  98  58 
DTP3 92  91  92  92  92  90  95  33 
HepB3 91  91  91  92  92 
HepB_BD
Hib3 91  91  92  92  92  90 
MCV1 93  94  94  94  94  91  86 
MCV2 93  92  91  90  88 
PCV3 91  91  91  91  91 
Pol3 92  91  92  92  92  90  72  17 
Rota_last 84  84  84  85  84 

Number of districts in the country Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
 
   
/
|
|
\
Greater or equal to 90% 100
From 80 to 89% 0
From 50 to 79% 0
Less than 50% 0
Proportion of districts
not reporting DTP3 coverage
0
 

Immunization Schedule (2014 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
DTaPHibHepIPV 2, 4, 6 months; Yes
DTaPIPV 4 years; Yes
HPV 10-15 years; Yes
HepA 12-24 months (x2); No Aboriginal and Torres Strait Islander
HepB birth; 10-15 years; Yes
HibMenC 12 months; Yes
Influenza_Adult >= 65 years; and adults with chronic illness, pregnant women and Aboriginal and Torre
Influenza_Pediatric Only for infants with chronic illness
MMR 12 months; Yes
MMRV 18 months; Yes
Pneumo_conj 2, 4, 6, 12, 12-18 months; Yes 12M Medically at Risk. 12-18M Aboriginal and Torres Strait Islander children in high risk areas
Pneumo_ps >=65 years; Yes 4Y Medically at Risk. 15+50+ Aboriginal and Torres Strait Islander People
Rotavirus 2, 4, 6 months; Yes
Tdap 10-15 years (x2); Yes
Varicella 10-15 years; Yes

Immunizaton indicators

Indicator Expected answer 2014  2013  2012  2011  2010  2009  2008 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes  Yes  Yes  Yes  No  No 
What years does the MYP cover? number 2013-2018  2013-2018  2009-2013      NA  NA 
Nº of districts with microplans that include activities to raise immunization coverage number          

System performance

Total Nº districts in country number
Nº districts with DTP3 coverage >=80% number
% of districts with DTP3 coverage >=80% From 0 to 100% 100  100  100  100  100  100  100 
Nº districts with measles (MCV1) coverage >=95% number
% of districts with MCV1 coverage >=95% From 0 to 100% 13  13  13  25  25  50 

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND Yes  Yes  No  No  No     
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Finance

Immunization expenditure financed, using Government funds? From 0 to 100% 100  100  100  NA  NA     

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR Yes  Yes  Yes  Yes  Yes     

Sources

 1  "The 2015 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2013, data for 2012
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.